News | PET Imaging | March 03, 2016

Patient Enrollment Opens For Largest Brain Amyloid Scanning Research Study

IDEAS Study offers reimbursement for PET imaging to help clarify diagnosis of dementia in patients in whom cause is uncertain

Alzheimer's disease, IDEAS study, patient enrollment open, amyloid PET scan

March 3, 2016 — Participating dementia specialists may now enroll patients in the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study at IDEAS-Study.org. Primary care and other doctors not taking part in the IDEAS Study are encouraged to refer eligible patients to participating physicians.

The IDEAS Study will follow more than 18,000 Medicare beneficiaries to determine the clinical value of a brain positron emission tomography (PET) scan to detect the hallmark brain amyloid accumulation of Alzheimer's disease in diagnosing and managing treatment of patients age 65 and older with mild cognitive impairment (MCI) or dementia of uncertain cause. Information from this scan can help exclude underlying Alzheimer's disease, and may help guide patient management.

"We are excited that approved physicians may begin registering patients for the IDEAS Study. We anticipate that results from the study will greatly inform future treatment and coverage decisions that can benefit countless Americans and others around the world," said Gil D. Rabinovici, M.D., IDEAS Study principal investigator and associate professor of neurology at the University of California, San Francisco.

Board-certified neurologists, psychiatrists and geriatric medicine physicians interested in enrolling eligible patients in the IDEAS Study, along with PET facilities that would like to join the study as imaging sites, may apply for participation online using the register/login portal. Participating physicians may enroll eligible patients using the same portal. Background on the study, requirements for participation and a set of frequently asked questions are available on the IDEAS website.

"The IDEAS Study will provide the evidence needed to demonstrate the utility of amyloid PET imaging in a clinical setting and for future decision making about insurance coverage for what we believe to be an important diagnostic tool," said Maria Carrillo, Ph.D., Alzheimer's Association chief science officer and IDEAS Study co-chair. "A swift and accurate diagnosis has a huge impact on access to Alzheimer's treatments, eligibility for research trials, plus much-needed support and information services."

The IDEAS Study will not directly recruit patients. Participants must instead be referred into the study by dementia specialists. Dementia specialists will enroll patients whose cases meet the study enrollment criteria and refer them for an amyloid PET scan. Amyloid PET scans will be performed and interpreted by a nuclear medicine physician or radiologist, with results provided to the ordering physician for disclosure to the patient and to support further diagnostic decisions. Scan results and diagnosis will be captured for the study.

Participating PET facilities and interpreting physicians will be reimbursed for the scans under the Centers for Medicare & Medicaid Services (CMS) Coverage with Evidence Development (CED) policy that requires research study participation as a condition of Medicare payment. This is currently the only way a brain amyloid PET scan will be covered for Medicare beneficiaries.

The IDEAS Study is led by the Alzheimer's Association and managed by the American College of Radiology (ACR) and American College of Radiology Imaging Network (ACRIN).

For more information: www.ideas-study.org

Related Content

Images from computed tomography (CT) colonography show segmented abdominal aortic calcification measured with semiautomated CT tool on coronal image. Within region of interest over aorta selected by user, tool automatically segments and quantifies aortic calcification (shown in blue). 

Image Credit: O’Connor S D, Graffy P M, Zea R, et al. Does nonenhanced CT-based quantification of abdominal aortic calcification outperform the Framingham Risk Score in predicting cardiovascular event sin asymptomatic adults? Radiology doi: 10.1148/radiol.2018180562. Published online Oct. 2, 2018. © RSNA.

News | Computed Tomography (CT) | October 12, 2018
Computed tomography (CT)-based measures of calcification in the abdominal aorta are strong predictors of heart attacks...
CORAR Supports Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc.
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
Surgery, Radiation Therapy Equally Effective in Treating Oropharyngeal Cancer
News | Radiation Therapy | October 09, 2018
A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness...
ASTRO 2018 Radiation Therapy Clinical Trials
Feature | ASTRO | October 08, 2018
October 8, 2018 — The American Society for Radiation Oncology (ASTRO) announced the 10 top-rated clinical studies tha
Adherence to Annual Lung Cancer Screening Needs Improvement
News | Lung Cancer | October 03, 2018
A study of adherence to annual low-dose computed tomography (LDCT) screening within the Veteran Health Administration...
Xoft Electronic Brachytherapy System Effective Long-Term for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 02, 2018
Breast cancer recurrence rates for patients treated with the Xoft Axxent Electronic Brachytherapy (eBx) System that...
CyberKnife System Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions
News | Stereotactic Body Radiation Therapy (SBRT) | September 27, 2018
Accuray Inc. announced that published data from two prospective, multi-center studies using differing protocols provide...
Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption
News | Nuclear Imaging | September 27, 2018
Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of...